CYBN Stock Analysis: Buy, Sell, or Hold?
CYBN - Cybin Inc.
$8.28
0.10 (1.22%)
▲
5d:
+0.85%
30d:
+50.27%
90d:
+33.33%
BUY
HIGH Confidence
Analysis Updated: Jan 2, 2026 12:00 AM ET
Earnings: Feb 09, 2026
0d
Get Alerted When CYBN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: CYBN shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: CYBN shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
In-depth Analysis How we analyze
Valuation Analysis: CYBN is currently trading at $8.28, which is considered fair based on recent price action.
Technical Outlook: Technically, CYBN is showing sideways momentum. Immediate support is located at $6.75, while resistance sits at $9.12.
Market Sentiment: CYBN has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $48.00 (+479.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, CYBN is showing sideways momentum. Immediate support is located at $6.75, while resistance sits at $9.12.
Market Sentiment: CYBN has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $48.00 (+479.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Company Quality Score
58/100
(HOLD)
Volume Confirmation
UNKNOWN
Confidence Score
81.6%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (60/100)
- BULLISH: Trading 479.7% below Wall St target ($48.00)
Support & Resistance Levels
Support Level
$6.75
Resistance Level
$9.12
Current Trend
Sideways
Technical data as of
Jan 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.05
Wall Street Target
$48.00
(+479.7%)
Share & Embed Analysis
Last updated: March 30, 2026 2:03 PM ET
Data refreshes hourly during market hours. Next update: 3:03 PM
Data refreshes hourly during market hours. Next update: 3:03 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CYBN showing a specific setup today?
Featured in Portfolios
CYBN is a key holding in these high-performance investment strategies.
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$25 | 52 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$411 | 48 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$111 | 57 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$8 | 48 HOLD |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$33 | 49 HOLD |
